ELCC 2018: Abstracts

Submit your abstract for ELCC 2018!

Submit your abstract for ELCC 2018

IMPORTANT

  1. To access the abstract submission system you will need to be logged in to your myESMO account. If you do not already have a user account,  please allow extra time to create one here and then return to this page to begin the abstract submission process.
  2. Please ensure that you have read the ELCC 2018 abstract regulations.

Abstract submission deadlines

Deadline Date and time
 Abstract submission system opening 21 September 2017

 

  • Abstracts
  • Trial in Progress
  • Intent to submit LBA

 

8 January 2018, 21:00 CET (Central European Time)
 Late-breaking abstracts (LBA) 5 March 2018, 21:00 CET (Central European Time)

Outcome notifications

Outcome notifications are expected to be made available to first authors by the end of January 2018.

Late-breaking abstracts

Late-breaking abstracts may be submitted for high quality, new research findings with implications for clinical practice or understanding of disease processes. The work must not have been previously published in any publication in a peer review setting or presented at a meeting of any other scientific organisation prior to ELCC 2018.Only abstracts for which no conclusive data are available at the time of the abstract submission deadline of 8 January 2018 will be considered for late-breaking status.A preliminary abstract indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by 8 January 2018 and the intent to submit a late-breaking abstract check-box must be ticked.Submitters of preliminary versions receiving approval to proceed must submit the final LBA by 5 March 2018, 21:00 CET (Central European Time).

Trial in Progress abstracts

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to ELCC 2018.It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

  • Background
  • Trial design

Notes:

  • Recruitment must have already begun or have been completed by the abstract submission deadline of 8 January 2018.
  • Abstracts including results or preliminary data will be rejected.
  • Authors of ‘encore’ TiP abstract submissions must supply information regarding the original presentation, indicating the name of the meeting and publication number. The first author will be responsible for obtaining, and, upon request, showing proof that written permission has been obtained from the copyright holder of the original abstract publication(s).

Trial in Progress abstracts will be accepted for Poster outcome only.

Presentation of accepted abstracts

The ELCC 2018 Scientific Committee will select abstracts for presentation during the Congress and determine the format of the presentations from the following possibilities:

  • Proffered Paper (oral presentation) – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
  • Poster Discussion – Presentation and analysis by an invited speaker highlighting important findings within a disease type or about a common theme plus interactive audience discussion.
  • Poster – An important method for communicating details of scientific research, posters will be on display for the duration of the Congress.

Travel grants

A restricted number of travel grants to ELCC 2018 are available, upon application, to first author (= presenter) of candidates under the age of 40 who submit abstracts considered deserving of recognition. Selection will be made by the ELCC 2018 Scientific Committee on a competitive basis from among the accepted abstracts.To apply for a travel grant, the following documents must be received by the ELCC Secretariat c/o the ESMO Congress Department on or before 8 January 2018:

  1. A letter of introduction by the applicant. Please include the following general information
    • How relevant are the topics presented during this Congress to your current practice and research?
    • Have you attended any event on a similar topic in the last 3 years?
    • How do you believe your attendance at this Congress will help you improve your knowledge in the field and your professional development?
    • How do you consider that the findings published in your abstract make a relevant contribution to the topics presented during this Congress?
    • Have you recently been awarded an ESMO travel grant? If yes, for which event?
     
  2. A copy of the submitted abstract (the applicant must be the first author and presenter)
  3. A readable photocopy of either identity card or passport
  4. A short curriculum vitae (maximum 2 pages)

Documentation must be sent by e-mail to travelgrants@esmo.org  The ELCC 2018 organisers will provide the recipients with a subsidised travel ticket, subsidised accommodation and Congress registration.Travel grant recipients must submit a report detailing the benefits of participating in ELCC 2018 by 15 June 2018.Incomplete applications will not be considered.